Replies to post #3005 on Gilead Sciences Inc (GILD)

[FooBarAndGrill]

This compassionate use case is not to be considered as evidence of anything at all. https://www.biopharmadive.com/news/coronavirus-remdesivir-gilead-antiviral-drug-covid-19/573261/

Statnews has published an article based on a non-peer-reviewed paper. Since the actual clinical trials are all blinded there is really no way to predict those results until the trial is complete. https://www.statnews.com/pharmalot/2020/03/13/gilead-coronavirus-covid19-clinical-trials/

The only definitive answer will be obtained by statistical analysis at the completion of the on-going clinical trials. We'll know top-line results very soon (in clinical trial terms this is a sprint).

[sharinky]

Gilead is giving out the drug for compassionate use. There have been multiple reports the last couple of weeks of patients who were on death's door (hence the compassionate use) who have recovered. Information is all around you if you look for it. There was the WSJ article on the NIH physician last week that was basically ignored. CNBC has been too busy pumping other stocks to report about GILD.